Loading
Journal of Cellular Immunology
ISSN: 2689-2812
CENTOGEN
France
Editor-in-Chief
Patrice P. DENEFLE, Ph.D, HDR, CEDEP INSEAD, is the former Head and General Manager of INSTITUT ROCHE and is currently serving as a Senior Advisor at LINKS CONSULTING. He also served as a Senior Vice President for DIGITAL & TRANSLATIONAL SCIENCES at IPSEN, an International Mid-size Biopharmaceutical company from 2010-2014. He has been previously in charge of multiple leadership positions in Innovation-driving programs in Large Pharma (Sanofi-Aventis, Aventis, RPR Gencell, RPR for 23 years), Biotechs (Genethon for 3 yrs) and mid-size Biopharma. Prof. Patrice P. DENEFLE received his Ph.D in Microbiology from Univ. Paris VII, Doctorate (HDR) in Pharmacology from Univ. Lille II. He is a qualified Professor in Molecular Biology (Sect 64) & Cell Biology (Sect 65), Associate Professor at Paris-Descartes University and lecturer in several ParisTech Graduate Schools. Prof. Patrice DENEFLE has published more than 150 scientific papers and patents. He is currently a member of several boards, R&D Strategic Committee of the MEDICEN Biocluster and the Research and Innovation Association of Health Industries (ARIIS) where he has been recently nominated President of the AI/Health strategic transformation Committee (CSF).
Apply state of the art Digital & Translational Sciences to bring Life Changing and Disease-Modifying Therapeutics to patients. Specialties: Broad and applied expertise in Biotechnology & Biotherapeutics, Lipid Biology & Atherosclerosis, Neurodegenerative Diseases, Oncology, Rare Diseases, Genetic Therapies, Human Genetics & Pharmacogenetics, Functional Genomics, Molecular and Clinical Pharmacology, Translational Research and Development, Precision Medicine (when Science meets Medicine).
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.